Search

Sartorius Stedim Biotech.

Atidarymo kaina

SektoriusFinansų sektorius

198.5 1.43

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

192.8

Max

198.4

Pagrindiniai rodikliai

By Trading Economics

Pajamos

4.9M

93M

Pardavimai

4.2M

766M

P/E

Sektoriaus vid.

63.311

21.67

Pelnas, tenkantis vienai akcijai

1.25

Dividendų pajamingumas

0.36

Pelno marža

12.146

Darbuotojai

10,477

EBITDA

9.2M

240M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+21.53% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.36%

4.41%

Kitas uždarbis

2026-10-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.1B

19B

Ankstesnė atidarymo kaina

197.07

Ankstesnė uždarymo kaina

198.5

Naujienos nuotaikos

By Acuity

50%

50%

161 / 436 reitingas Finance

Sartorius Stedim Biotech. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-27 23:56; UTC

Correlated Moves
News

Royal Gold shares are higher in after-market trading following CEO Bill Heissenbuttel's upcoming presentation at the Jefferies Global Industrials Conference on September 10.

2026-08-27 23:56; UTC

Correlated Moves
News

Diamondback Energy has risen in after-market hours following its joint venture for the Solitude Pipeline System, with analysts estimating a fair value of $232.17.

2026-08-27 23:51; UTC

News

Carlyle Group reported second-quarter revenue exceeding analyst expectations. In after-market trading, shares are advancing, reflecting a solid performance backdrop.

2026-08-27 23:51; UTC

Correlated Moves
News

The USD/HUF is trading higher, reflecting gains since Wednesday. A decline in initial jobless claims suggests strength in the U.S. economy.

2026-08-27 23:31; UTC

News

NAPCO Security Technologies Inc shares are lower in after-market hours, following broader market declines despite a 10% revenue increase in the fiscal fourth quarter.

2026-08-27 23:26; UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, amid a decline in the US 10Y Treasury Bond Index and investor sentiment shifts.

2026-08-27 23:11; UTC

News

Shares of Regenxbio are higher in after-market trading following a $949.4K insider purchase by director Gregor Ciongoli of 102.6K shares.

2026-08-27 23:06; UTC

Social Media
News

BioNTech SE's COVID-19 vaccine COMIRNATY® XFG receives FDA approval for adults 65 and older. Shares are trading higher in after-market hours.

2026-08-27 23:06; UTC

News

Shoals Technologies Group Inc shares declined in after-market trading despite winning a patent case against Voltage, LLC, with a jury awarding over $96 million.

2026-08-27 23:02; UTC

News

Permian Resources Corp shares are higher in after-market hours, boosted by Citigroup's outlook on the Permian Basin becoming the top U.S. natural gas producer.

2026-08-27 23:02; UTC

News

PDD Holdings reported second-quarter revenue of RMB112.4 billion, missing estimates. Shares are roughly flat in after-market trading amid rising operating expenses.

2026-08-27 23:02; UTC

Correlated Moves
News

Coinbase Global Inc. announced a token-backed mortgage product with Better Mortgage, boosting shares modestly higher in after-market trading.

2026-08-27 23:02; UTC

Social Media
News

Salesforce Inc. remains roughly flat in after-market hours amid discussions on short-selling dynamics and positive user experiences with its CRM system.

2026-08-27 23:02; UTC

News

Revolution Medicines Inc shares are higher in after-market trading following FDA approval of RASONQUE for metastatic pancreatic cancer, discussed during an August 26 conference call.

2026-08-27 23:02; UTC

News

Main Street Capital plans a supplemental dividend for December 2026, continuing its $0.30-per-share quarterly distribution. Shares are trading higher in after-market hours.

2026-08-27 23:02; UTC

Social Media
News

CrowdStrike Holdings Inc shares are lower in after-market hours, reflecting broader market declines despite recent strong earnings and positive revenue outlook.

2026-08-27 23:02; UTC

News

SFL Corporation reported Q2 revenue of $200.77 million and net income of $33.79 million. Shares are higher in after-market trading following the announcement.

2026-08-27 23:02; UTC

Social Media
Event
News

Gap Inc. shares rise in after-market trading following Q2 earnings that beat EPS estimates and included an adjusted EPS guidance increase.

2026-08-27 23:02; UTC

Social Media
News

Ulta Beauty Inc. shares are lower in after-market trading despite reporting strong second-quarter earnings and raising fiscal year guidance for net sales growth.

2026-08-27 23:02; UTC

News

Constellation Brands names Alex Alvarez as chief supply chain officer for its beer division. Shares are higher in after-market trading following initial dips.

2026-08-27 23:02; UTC

News

Rivian Automotive shares fell in after-market trading after CFO Claire McDonough announced her departure for GE Vernova, effective October 30.

2026-08-27 23:02; UTC

Event
Social Media
News

Affirm Holdings shares rise in after-market hours following a record fiscal fourth-quarter profit and revenue of $1.17 billion, exceeding estimates.

2026-08-27 23:02; UTC

Social Media
News

Pfizer and BioNTech received FDA approval for their XFG-adapted COVID-19 vaccine, COMIRNATY XFG, boosting shares in after-market trading.

2026-08-27 23:02; UTC

Social Media
News

Marvell Technology reported Q2 revenue of $2.74 billion, exceeding estimates, but shares are trading lower in after-market hours following the results.

2026-08-27 23:02; UTC

News
Correlated Moves

USD/PLN is gaining modestly today, influenced by initial jobless claims falling to 203,000, indicating ongoing strength in the labor market.

2026-08-27 23:02; UTC

Correlated Moves
Social Media
News

NVIDIA pauses revenue-sharing deals with AI cloud firms amid antitrust concerns, contributing to a modest decline in shares during after-market hours.

2026-08-27 23:02; UTC

Social Media
News

Veeva Systems Inc shares are lower in after-market trading, reflecting a broader market downturn despite earlier gains. The stock remains strong relative to its 20-day moving average.

2026-08-27 23:02; UTC

News

Bilibili Inc shares declined during after-market hours despite reporting strong growth in daily active users and advertising revenue. The stock remains below its 20-day moving average.

2026-08-27 23:01; UTC

News

Otis Worldwide Corp shares are lower in after-market trading, despite securing a significant contract for modernization at Tianjin 117 Tower in China.

2026-08-27 23:01; UTC

News
Correlated Moves

Intuit Inc. shares are lower in after-market trading following a downgrade by BofA Securities, which cut its fiscal 2027 revenue estimate to $23.4 billion.

Akcijų palyginimas

Kainos pokytis

Sartorius Stedim Biotech. Prognozė

Kainos tikslas

By TipRanks

21.53% į viršų

12 mėnesių prognozė

Vidutinis 233.33 EUR  21.53%

Aukščiausias 260 EUR

Žemiausias 210 EUR

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Sartorius Stedim Biotech. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

6 ratings

6

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

161 / 436 reitingas Finansų sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat